Table 2.
Initial and treated mean values (standard error) of BPs, heart rate, and peripheral vascular (Brachial artery) dilation and analysis of variance results (see text for description of analyses, age and gender were used as covariates in these analyses).
| Measure | Lisinopril Group (n=12) |
Atenolol Group (n=16) |
Statistical Pre- Treatment: Group |
Results Pre to Post Treatment |
Group by Pre-Post Treatment |
||
|---|---|---|---|---|---|---|---|
| Pre- Treatment |
Post- Treatment |
Pre- Treatment |
Post- Treatment |
F-value p: | F-value p: |
F-value p: | |
| SBP (mmHg) | 148. 7(3.2) | 127.0 (3.6) | 147.7(2.7) | 124.0 (3.1) | .1 ns | 72.2 <.001 | .3 ns |
| DBP (mmHg) | 93.3(2.6) | 79.3(2.7) | 98.3 (2.3) | 80.9 (2.4) | 1.2 ns | 78.5 <.001 | .8 ns |
| Heart Rate (bpm) | 71.4 (2.8) | 66.8 (2.7) | 76.0 (2.5) | 62.0(2.4) | 1.9 ns | 27.6 <.001 | 6.01 <.01 |
| Percent brachial artery dilation | 4.4 (1.0) | 7.1 (1.0) | 4.5 (.8) | 7.0 (.8) | .1 ns | 7.6 <.01* | .0 ns |
*
F (1,20)=7.4, p=.01 for percent vascular dilation uncorrected for initial baseline.